Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Index funds provide low fees and broad market exposure that can simplify retirement investing while aiming for steady growth over time. This guide highlights the why and how.
22,451 articlesA bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
shark tank’s kevin o’leary identifies two booming opportunities in AI for 2026: helping small businesses deploy AI to...
Oil approaching $100 per barrel could upend retail economics. Walmart appears best positioned to weather an energy-dr...
A new Bitcoin mining cost model, tested with Riot Platforms data, finds power costs can be covered only at a BTC pric...
Geopolitical conflicts are upending the classic playbook for U.S. stocks. The S&P 500 has not followed the traditiona...
A Senate staff brief on the ROAD to Housing Act flags design flaws and local zoning reliance, signaling lenders and b...
Applied Materials reports a robust free cash flow figure for Q1 2026, but the stock fell as traders questioned how lo...
Oil prices cooled after news that wealthy nations may coordinate an emergency reserve release. Analysts warn that pri...
Oil futures rose midweek as markets priced in a possible emergency release from the U.S. Strategic Petroleum Reserve ...
Rising tensions around Iran are lifting jet fuel costs and pressuring airline tickets globally. Here’s what travelers...
As labor markets stay tight, businesses are learning that unlocking discretionary effort hinges on culture and frontl...
As tariffs re-emerge under Section 301, policymakers push a framework that has endured decades of legal challenges. T...